With streamlined, “sitevisitless” CCSG review in place, cancer centers remained stable in 2025

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Earlier this month, NCI released a new Cancer Center Support Grant Notice of Funding Opportunity. Except for the elimination of the Plan to Enhance Diversity component and lengthening of the Shared Resource write-ups from three to six pages, the guidelines are essentially unchanged. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Richard J. Jones, MD
Professor of oncology and medicine, Director, Bone Marrow Transplantation Program, Co-Director, Hematologic Malignancies Programs, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins
Table of Contents

YOU MAY BE INTERESTED IN

Leadership is changing at The Wistar Institute and the Helen F. Graham Cancer Center & Research Institute in the months to come—but the leaders of the two institutions say that this will have little if any effect on the clinical-research collaboration that they have spent the past 15years building (The Cancer Letter, July 12, 2019). 
Richard J. Jones, MD
Professor of oncology and medicine, Director, Bone Marrow Transplantation Program, Co-Director, Hematologic Malignancies Programs, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login